US Broker Ratings

Phreesia, Inc. (PHR) Stock Analysis: Healthcare SaaS Leader with 44% Upside Potential

Phreesia, Inc. (NYSE: PHR), a key player in the healthcare sector, offers a compelling investment narrative for investors seeking exposure to the rapidly evolving Health Information..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Evaluating a 29.86% Potential Upside in the Biotech Sector

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based clinical-stage biotechnology company, is capturing the attention of investors with its promising research in inflammatory skin and joint diseases. Despite..

PACS Group, Inc. (PACS) Stock Analysis: Unpacking a 175% Potential Upside

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, is capturing investor attention with its considerable potential upside of 175.13%. As a company specializing..

Enovis Corporation (ENOV) Stock Analysis: A Robust 51.15% Potential Upside Captures Investor Attention

Enovis Corporation (ENOV), a key player in the healthcare sector’s medical device industry, presents a compelling case for investors seeking growth opportunities within this dynamic field...

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Uncovering Growth Potential and Strategic Collaborations

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company based in Salt Lake City, Utah, is making waves in the healthcare sector with its innovative approach..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook on a Biotech Jewel with a 46% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out in the biotechnology sector, attracting significant attention from investors due to its innovative approach to treating rare neurological..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 24% Upside Potential with Robust Revenue Growth

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing the attention of investors with its promising 24.21% upside potential, as indicated by the average analyst target price. As..

Certara, Inc. (CERT) Stock Analysis: Exploring a 17.91% Upside Potential in Health Information Services

Certara, Inc. (NASDAQ: CERT) stands as a prominent player in the health information services sector, specializing in technology-enabled solutions for biosimulation in drug development and regulatory..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Unpacking a 49% Revenue Growth in the Healthcare Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC), a dynamic player in the healthcare sector, has been catching the eye of investors with its impressive 49% revenue growth. Specializing..

Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings Amidst Robust Revenue Growth

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a noteworthy name in the biotechnology sector, commanding a market capitalization of $3.7 billion. Headquartered in Jupiter, Florida, Ligand is..

Protagonist Therapeutics (PTGX) Stock Analysis: Exploring Growth Potential with Promising Pipeline

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical company specializing in peptide therapeutics, has been capturing investor interest with its robust pipeline and notable market presence. Operating..

Privia Health Group, Inc. (PRVA): Investor Outlook with a Promising 17.89% Upside

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector as a prominent player in the health information services industry. With a market..

NewAmsterdam Pharma (NAMS) Investor Outlook: Strong Buy Ratings and Promising Growth Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a burgeoning force in the biotechnology sector, has been capturing investor interest with its innovative approach to tackling metabolic diseases...

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: 75% Potential Upside Awaits Investors

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is making waves in the biotechnology sector with its innovative approach to treating rare diseases. Headquartered in Princeton, New Jersey, this..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Promising 35% Upside as Analysts Rally Behind This Biotech

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biotechnology company headquartered in Altrincham, UK, is capturing the attention of investors with its robust pipeline targeting unmet medical..

Twist Bioscience Corporation (TWST) Stock Analysis: A 15% Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST) is garnering attention in the investment community with its significant presence in the healthcare sector, particularly within diagnostics and research. With..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 44.65% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) has captured investor interest with a compelling 44.65% potential upside, according to the latest analyst ratings. As a rising star in the..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Analysts See 67.70% Potential Upside

Apogee Therapeutics, Inc. (APGE), a burgeoning player in the biotechnology sector, has been garnering investor attention with its promising pipeline in the treatment of various inflammatory..

Galapagos NV (GLPG) Stock Analysis: Navigating the Waters of Biotech with Potential Challenges Ahead

Galapagos NV (GLPG), a prominent player in the biotechnology sector, is navigating a complex landscape as it ventures into oncology and immunology. Headquartered in Mechelen, Belgium,..

Arrowhead Pharmaceuticals (ARWR) Investor Outlook: Promising Growth with a 20% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a key player in the biotechnology sector focused on developing breakthrough treatments for intractable diseases, is attracting significant attention from individual..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds